{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:23:13Z","timestamp":1790677393940,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,19]],"date-time":"2015-07-19T00:00:00Z","timestamp":1437264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"crossref","award":["Grant code:152001005"],"award-info":[{"award-number":["Grant code:152001005"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["Grant code:OP07-08"],"award-info":[{"award-number":["Grant code:OP07-08"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["Grant code:201678"],"award-info":[{"award-number":["Grant code:201678"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13023-015-0303-0","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T00:54:39Z","timestamp":1437180879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12\u00a0week training program"],"prefix":"10.1186","volume":"10","author":[{"given":"Linda E. M.","family":"van den Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marein M.","family":"Favejee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan C. A.","family":"Wens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Kruijshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan F. E.","family":"Praet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold J. J.","family":"Reuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes B. J.","family":"Bussmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,19]]},"reference":[{"key":"303_CR1","first-page":"1559","volume-title":"Myology","author":"AG Engel","year":"2004","unstructured":"Engel AG, Hirschhorn R, Huie MI. Acid maltase deficiency. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw-Hill; 2004. p. 1559\u201386."},{"issue":"9646","key":"303_CR2","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT van der Ploeg","year":"2008","unstructured":"van der Ploeg AT, Reuser AJ. Pompe's disease. Lancet.2008;372(9646):1342\u201353.","journal-title":"Lancet"},{"issue":"3","key":"303_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/brain\/93.3.599","volume":"93","author":"AG Engel","year":"1970","unstructured":"Engel AG. Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain. 1970;93(3):599\u2013616.","journal-title":"Brain"},{"key":"303_CR4","doi-asserted-by":"crossref","unstructured":"Laforet P, Nicolino M, Eymard PB, Puech JP, Caillaud C, Poenaru L, et al. Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology. 2000;55(8):1122\u20138.","DOI":"10.1212\/WNL.55.8.1122"},{"key":"303_CR5","doi-asserted-by":"crossref","unstructured":"van der Beek NA, de Vries JM, Hagemans ML, Hop WC, Kroos MA, Wokke JH, et al. Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet J Rare Dis. 2012;7:88.","DOI":"10.1186\/1750-1172-7-88"},{"key":"303_CR6","doi-asserted-by":"crossref","unstructured":"de Vries JM, van der Beek NA, Hop WC, Karstens FP, Wokke JH, de Visser M, et al. Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study. Orphanet J Rare Dis. 2012;7:73.","DOI":"10.1186\/1750-1172-7-73"},{"key":"303_CR7","doi-asserted-by":"crossref","unstructured":"Gungor D, Kruijshaar ME, Plug I, D'Agostino RB, Hagemans ML, van Doorn PA, et al. Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet J Rare Dis. 2013;8:49.","DOI":"10.1186\/1750-1172-8-49"},{"issue":"4","key":"303_CR8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","volume":"260","author":"A Toscano","year":"2013","unstructured":"Toscano A, Schoser B. Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol. 2013;260(4):951\u20139.","journal-title":"J Neurol"},{"key":"303_CR9","doi-asserted-by":"crossref","unstructured":"Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J, et al. Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve. 2007;35(1):70\u20137.","DOI":"10.1002\/mus.20665"},{"key":"303_CR10","doi-asserted-by":"crossref","unstructured":"Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C, et al. Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol. 2010;257(1):91\u20137.","DOI":"10.1007\/s00415-009-5275-3"},{"issue":"1\u20132","key":"303_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ymgme.2012.07.014","volume":"107","author":"MM Favejee","year":"2012","unstructured":"Favejee MM, Huisstede BM, Bussmann JB, Kruijshaar ME, van der Ploeg AT. Physiotherapy management in late-onset Pompe disease: clinical practice in 88 patients. Mol Genet Metab. 2012;107(1\u20132):111\u20135.","journal-title":"Mol Genet Metab"},{"issue":"11 Suppl","key":"303_CR12","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1097\/00002060-200211001-00007","volume":"81","author":"PM Clarkson","year":"2002","unstructured":"Clarkson PM, Hubal MJ. Exercise-induced muscle damage in humans. Am J Phys Med Rehabil. 2002;81(11 Suppl):S52\u201369.","journal-title":"Am J Phys Med Rehabil"},{"issue":"2","key":"303_CR13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2340\/1650197719702239298","volume":"2","author":"G Borg","year":"1970","unstructured":"Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2(2):92\u20138.","journal-title":"Scand J Rehabil Med"},{"key":"303_CR14","first-page":"62","volume-title":"Principles of exercise testing","author":"K Wasserman","year":"1999","unstructured":"Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ. Measurements during integrative cardiopulmonary exercise testing. In: Weinberg R, editor. Principles of exercise testing. Baltimore: Lippincott, Williams and Wilkins; 1999. p. 62\u201394."},{"issue":"4","key":"303_CR15","first-page":"517","volume":"15","author":"KL Parkhouse","year":"2011","unstructured":"Parkhouse KL, Ball N. Influence of dynamic versus static core exercises on performance in field based fitness tests. J Bodyw Mov Ther. 2011;15(4):517\u201324.","journal-title":"J Bodyw Mov Ther"},{"key":"303_CR16","doi-asserted-by":"crossref","unstructured":"Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981;4(3):186\u201397.","DOI":"10.1002\/mus.880040304"},{"key":"303_CR17","doi-asserted-by":"crossref","unstructured":"van Capelle CI, van der Beek NA, de Vries JM, van Doorn PA, Duivenvoorden HJ, Leshner RT, et al. The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients. J Inherit Metab Dis. 2012;35(2):317\u201323.","DOI":"10.1007\/s10545-011-9388-3"},{"key":"303_CR18","doi-asserted-by":"crossref","unstructured":"van den Berg LE, Zandbergen AA, van Capelle CI, de Vries JM, Hop WC, van den Hout JM, et al. Low bone mass in Pompe disease: muscular strength as a predictor of bone mineral density. Bone. 2010;47(3):643\u20139.","DOI":"10.1016\/j.bone.2010.06.021"},{"issue":"8","key":"303_CR19","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1519\/JSC.0b013e3181e8a4be","volume":"25","author":"MS Lo","year":"2011","unstructured":"Lo MS, Lin LL, Yao WJ, Ma MC. Training and detraining effects of the resistance vs. endurance program on body composition, body size, and physical performance in young men. J Strength Cond Res. 2011;25(8):2246\u201354.","journal-title":"J Strength Cond Res"},{"key":"303_CR20","volume":"12","author":"R Quinlivan","year":"2011","unstructured":"Quinlivan R, Vissing J, Hilton-Jones D, Buckley J. Physical training for McArdle disease. Cochrane Database Syst Rev. 2011;12, CD007931.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"303_CR21","first-page":"272","volume":"26","author":"RJ Shephard","year":"1968","unstructured":"Shephard RJ. Intensity, duration and frequency of exercise as determinants of the response to a training regime. Int Z Angew Physiol. 1968;26(3):272\u20138.","journal-title":"Int Z Angew Physiol"},{"key":"303_CR22","doi-asserted-by":"crossref","unstructured":"Sveen ML, Jeppesen TD, Hauerslev S, Kober L, Krag TO, Vissing J. Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Brain. 2008;131(Pt 11):2824\u201331.","DOI":"10.1093\/brain\/awn189"},{"key":"303_CR23","doi-asserted-by":"crossref","unstructured":"Crescimanno G, Modica R, Lo Mauro R, Musumeci O, Toscano A, Marrone O. Role of the cardio-pulmonary exercise test and six-minute walking test in the evaluation of exercise performance in patients with late-onset Pompe disease. Neuromuscul Disord. 2015;25(7):542\u20137.","DOI":"10.1016\/j.nmd.2015.03.010"},{"issue":"5","key":"303_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1249\/MSS.0b013e31823e6579","volume":"44","author":"M Marzorati","year":"2012","unstructured":"Marzorati M, Porcelli S, Reggiori B, Morandi L, Grassi B. Improved exercise tolerance after enzyme replacement therapy in Pompe disease. Med Sci Sports Exerc. 2012;44(5):771\u20135.","journal-title":"Med Sci Sports Exerc"},{"key":"303_CR25","doi-asserted-by":"crossref","unstructured":"Goemans N, Klingels K, van den Hauwe M, Van Orshoven A, Vanpraet S, Feys H, et al. Test-retest reliability and developmental evolution of the 6-min walk test in Caucasian boys aged 5\u201312 years. Neuromuscul Disord. 2013;23(1):19\u201324.","DOI":"10.1016\/j.nmd.2012.10.019"},{"key":"303_CR26","doi-asserted-by":"crossref","unstructured":"McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, Atkinson L, et al. The 6-minute walk test in Duchenne\/Becker muscular dystrophy: longitudinal observations. Muscle Nerve. 2010;42(6):966\u201374.","DOI":"10.1002\/mus.21808"},{"key":"303_CR27","doi-asserted-by":"crossref","unstructured":"Nilsson MI, Samjoo IA, Hettinga BP, Koeberl DD, Zhang H, Hawke TJ, et al. Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease. Mol Genet Metab. 2012;107(3):469\u201379.","DOI":"10.1016\/j.ymgme.2012.09.010"},{"key":"303_CR28","doi-asserted-by":"crossref","unstructured":"Terzis G, Krase A, Papadimas G, Papadopoulos C, Kavouras SA, Manta P. Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol Genet Metab. 2012;107(4):669\u201373.","DOI":"10.1016\/j.ymgme.2012.10.020"},{"issue":"5","key":"303_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/01.gim.0000217789.14470.c5","volume":"8","author":"LE Case","year":"2006","unstructured":"Case LE, Kishnani PS. Physical therapy management of Pompe disease. Genet Med. 2006;8(5):318\u201327.","journal-title":"Genet Med"},{"key":"303_CR30","doi-asserted-by":"crossref","unstructured":"Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, et al. Pompe disease diagnosis and management guideline. Genet Med. 2006;8(5):267\u201388.","DOI":"10.1097\/01.gim.0000218152.87434.f3"},{"issue":"11 Suppl","key":"303_CR31","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1097\/00002060-200211001-00019","volume":"81","author":"WM Fowler Jr","year":"2002","unstructured":"Fowler Jr WM. Role of physical activity and exercise training in neuromuscular diseases. Am J Phys Med Rehabil. 2002;81(11 Suppl):S187\u201395.","journal-title":"Am J Phys Med Rehabil"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-015-0303-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-015-0303-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-015-0303-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-015-0303-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T09:14:59Z","timestamp":1691831699000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-015-0303-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1186\/s13023-015-0303-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,19]]},"assertion":[{"value":"17 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"87"}}